Avanza Medical Research Center

Pensacola, Florida 32603

3 studies enrolling now · 19 studies all time

What they study most

Asthma, COVID-19, Chronic Migraine, Cystic Fibrosis, Diabetes Complications, Diabetes Mellitus, Diabetic Nephropathies, Endocrine System Diseases, Enteric Hyperoxaluria, Episodic Migraine, Gastroesophageal Reflux Disease, Glomerulonephritis

Studies at this site

• A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma — Recruiting now
• A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts — Recruiting now
• FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression — Starting soon
• A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine — Stopped early
• Baroreflex Activation Therapy for Heart Failure — Completed
• A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine — Stopped early
• A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine — Running, not enrolling
• A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine — Running, not enrolling
• Study of Obeldesivir in Children and Adolescents With COVID-19 — Stopped early
• A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease — Completed
• Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults — Completed
• Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
• A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension — Stopped early
• 20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants — Completed
• A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis — Status unconfirmed
• A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease — Stopped early
• Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria — Stopped early
• Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like Symptoms — Completed
• Gastrointestinal Tolerance Evaluation of an Infant Formula — Completed